Cambridge Sleep Sciences Ltd launches 'SleepHubT'

RNS Number : 9734C
Barkby Group PLC (The)
23 October 2020
 

23 October 2020

 

 

The Barkby Group PLC

 

("Barkby" or the "Company")

 

Cambridge Sleep Sciences Ltd launches 'SleepHub™' - A device to help restore natural sleep

 

Further to the acquisition of the IP of Cambridge Sound Technologies UK Ltd in April 2020 and in line with our business plan to launch a product in the second half of 2020, Barkby, the diversified business group, is pleased to announce that its subsidiary Cambridge Sleep Sciences Ltd has launched its brand-new product, SleepHub™, a device which improves and facilitates natural sleep.

 

SleepHub™is designed to help restore natural sleep cycles and improve wellbeing by using rhythms and pulses to emulate brain waves produced during sleep.

 

The product will retail at £599 per unit in the UK and is now available online at sleephub.com, and through selected partners. Sleep technology is an increasing area of focus and a growth area in the wider holistic wellness space which Cambridge Sleep Sciences Ltd is aiming to be at the forefront of.

 

Cambridge Sleep Sciences Ltd is in advanced discussions with a number of major retailers who are interested in stocking the product and we will update shareholders on progress in due course. 

 

 

Charles Dickson, Executive Chairman of The Barkby Group Plc, commented:

 

"We are extremely excited by the significant benefits that SleepHub™ can deliver, helping them address the root cause of poor-quality sleep and insomnia.  Through the combination of science and technology we have developed an excellent product that has the potential to free individuals from sleep anxiety and the side effects of sleep deprivation, which can lead to a range of physical and mental health issues."

 

 

Enquiries: 

 

The Barkby Group PLC

 

Charles Dickson, Executive Chairman

Douglas Benzie, Chief Financial Officer

 

 

 

 

finnCap Ltd (Nomad and Broker)

+44 (0) 20 7220 0500

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

 

Camarco (Financial PR)

+44 (0) 20 3757 4994

Jennifer Renwick/Jake Thomas

 

 

 

Notes to editors

About SleepHub™:

SleepHub™ is designed to help restore natural sleep cycles and improves wellbeing. It has four modes scientifically designed to act as a natural sleep aid by using rhythms and pulses to emulate brain waves produced during sleep.

The four modes guide the consumer through a series of sleep cycles to support them throughout the night and imitate the brain's natural sleep patterns. A variety of soundscapes complement each mode, enabling the brain to relax and find its natural sleep pattern. These sounds enable the brain to re-train and revert to those natural sleep cycles and help the consumer feel reinvigorated.  

 

About The Barkby Group Plc:

The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive.

In addition to these businesses, Barkby Life Sciences has invested in VivoPlex, a digital health company aiming to transform Women's Health with precision medicine, and it has signed an agreement with Cambridge Sound Technologies UK Ltd for the exclusive design of, and acquisition of the intellectual property rights related to, a device to improve and facilitate natural sleep

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQLLFLBBLLFBX
UK 100

Latest directors dealings